ABK Biomedical

ABK Biomedical Inc. is a Halifax, Nova Scotia medical device company founded in 2012 as a spin-out of Dalhousie University, developing and manufacturing imageable embolic microspheres for interventional oncology. Its lead product, Eye90 microspheres, is a yttrium-90 radioembolization device built on a proprietary imageable glass composition that is directly visible under fluoroscopy, X-ray and CT during and after the procedure, and it was granted FDA Breakthrough Device Designation for unresectable hepatocellular carcinoma and studied in the ROUTE90 pivotal trial. Its Easi-Vue embolic microspheres received FDA 510(k) clearance for embolization of hypervascular tumors and arteriovenous malformations. Devices are produced in the company's own cleanroom manufacturing facility in Halifax, with a second office in Ladera Ranch, California. ABK Biomedical is a regulated medical device manufacturer rather than a software vendor, and as of this profile it publishes no developer program, API documentation, SDK, or machine-readable API contract of any kind.

ABK Biomedical is profiled on the APIs.io network. Tagged areas include Medical Devices, Interventional Oncology, Radioembolization, Medical Imaging, and Oncology.

2.9/100 minimal Agent 3/100 human only Full breakdown ↓
scored 2026-09-06 · rubric v0.19.0
0 APIs
Medical DevicesInterventional OncologyRadioembolizationMedical ImagingOncologyHealthcareManufacturingCanadaCompany

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-06 · rubric v0.19.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/abkbiomedical: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Abkbiomedical Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Company 2

The organization behind the API

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: abkbiomedical
name: ABK Biomedical
description: ABK Biomedical Inc. is a Halifax, Nova Scotia medical device company founded in 2012 as a spin-out of Dalhousie
  University, developing and manufacturing imageable embolic microspheres for interventional oncology. Its lead product, Eye90
  microspheres, is a yttrium-90 radioembolization device built on a proprietary imageable glass composition that is directly
  visible under fluoroscopy, X-ray and CT during and after the procedure, and it was granted FDA Breakthrough Device Designation
  for unresectable hepatocellular carcinoma and studied in the ROUTE90 pivotal trial. Its Easi-Vue embolic microspheres received
  FDA 510(k) clearance for embolization of hypervascular tumors and arteriovenous malformations. Devices are produced in the
  company's own cleanroom manufacturing facility in Halifax, with a second office in Ladera Ranch, California. ABK Biomedical
  is a regulated medical device manufacturer rather than a software vendor, and as of this profile it publishes no developer
  program, API documentation, SDK, or machine-readable API contract of any kind.
url: https://raw.githubusercontent.com/api-evangelist/abkbiomedical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Medical Devices
- Interventional Oncology
- Radioembolization
- Medical Imaging
- Oncology
- Healthcare
- Manufacturing
- Canada
- Company
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://abkbiomedical.com/
- type: LinkedIn
  url: https://ca.linkedin.com/company/abk-biomedical-inc-
- type: SecondaryMarket
  url: https://equityzen.com/company/abkbiomedical
- type: DomainSecurity
  url: security/abkbiomedical-domain-security.yml
x-tier: profiled
x-tier-reason: 'enrichment pass 2026-09-06: full STEP 0b contract discovery run against every known host, no public API surface
  found'
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'ABK Biomedical manufactures implantable radioembolization and embolic microspheres (Eye90, Easi-Vue) in its own
    Halifax cleanroom rather than software: no api., developer., dev., portal., app. or data. host exists in DNS, there is
    no GitHub organization and no package under this name on npm or PyPI, and abkbiomedical.com is a SiteGround-hosted marketing
    site whose every path — /robots.txt included — answers HTTP 202 with an sg-captcha interstitial rather than any document.'
  evidence:
  - url: https://abkbiomedical.com/.well-known/api-catalog
    status: 202
  - url: https://abkbiomedical.com/openapi.json
    status: 202
  - url: https://api.github.com/orgs/abkbiomedical
    status: 404
  - url: https://pypi.org/pypi/abkbiomedical/json
    status: 404
  - url: https://registry.npmjs.org/-/v1/search?text=abkbiomedical
    status: 200
  - url: https://equityzen.com/company/abkbiomedical
    status: 200
  checked: '2026-09-06'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/abkbiomedical"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/abkbiomedical/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/abkbiomedical/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.